Go back

Qsauri
"B"

bundling
Guideline or reference source
CDRH Center for Devices & Radiological Health, FDA, Guidance for Industry and FDA Staff: Bundling Multiple Devices or Multiple Indications in a Single Submission, 2003
WHO Glossary
Definition
Refers to the inclusion of multiple devices or multiple indications for use for a device in a single premarket submission, including products subject to the device and biologics license application (BLA) authorities, for purposes of review and user fee payment. In CBER, the term may also include the designation of separate submissions as one premarket submission for review and user fee payment. Multiple devices may include different models within a generic type of device2 or devices that are of differing generic types.   Bundling is a marketing strategy that involves offering several products for sale as one combined product.
Narrower Term
combination pack
Related Term
combination product
 

Send comments to info@celegence.com Please read disclaimer before using Qsauri.